tm logo
CARNEXIV
REGISTERED

on 27 Jun 2019

Last Applicant/ Owned by

LUNDBECK LLC

Six Parkway NorthDeerfield, IL 60015

US

Serial Number

1834728 filed on 27th Apr 2017

Registration Number

TMA1033255 registered on 27th Jun 2019

Registration expiry Date

27th Jun 2029

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

CARNEXIV

Trademark usage description

pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or ac Read More

Classification Information


Class [005]
Pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely, dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, ADHD, migraine, pain, alcoholism and dependency; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, ADHD, migraine, pain, alcoholism and dependency; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, ADHD, migraine, pain, alcoholism and dependency; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, ADHD, migraine, pain, alcoholism and dependency; diagnostic reagents and agents for medical diagnostic use.


Classification kind code

11

Mark Details


Serial Number

1834728

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 55
on 27th Jun 2019
Registered
Submitted for opposition 50
on 28th Sep 2018
Allowed
Submitted for opposition 51
on 28th Sep 2018
Allowance Notice Sent
Submitted for opposition 42
on 13th Jun 2018
Advertised
Submitted for opposition 26
on 07th Jun 2018
Approved
Submitted for opposition 22
on 19th Apr 2018
Search Recorded
Submitted for opposition 27
on 19th Apr 2018
Approval Notice Sent
Submitted for opposition 31
on 01st May 2017
Formalized
Submitted for opposition 1
on 28th Apr 2017
Created
Submitted for opposition 30
on 27th Apr 2017
Filed